Civic Intelligence

Subcutaneous Drug Development & Delivery Consortium Inc

990 • Fiscal year 2024 • EIN 85-0837695

Jan 01, 2024 to Dec 31, 2024 • Filed on Mar 07, 2025

3855 SW 153rd DriveBeaverton, OR 97003

(503) 619-0505

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

65th percentile

0.26x

Higher debt load relative to assets than 65% of similar nonprofits.

2024 filings • 501(c)6 • $1M-$5M nonprofits • Source year 2024

Liabilities / Revenue

77th percentile

0.42x

Higher debt load relative to revenue than 77% of similar nonprofits.

2024 filings • 501(c)6 • $1M-$5M nonprofits • Source year 2024

Net Margin

92nd percentile

32%

Higher net margin than 92% of similar nonprofits.

2024 filings • 501(c)6 • $1M-$5M nonprofits • Source year 2024

Top Officer Pay

29th percentile

$0

Higher top officer pay than 29% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2024 filings • 501(c)6 • $1M-$5M nonprofits • Source year 2024

Asset Growth

88th percentile

28%

Faster asset growth than 88% of similar nonprofits.

2024 filings • 501(c)6 • $1M-$5M nonprofits • Annualized from 2023 to 2024

Revenue Growth

19th percentile

-5.3%

Faster revenue growth than 19% of similar nonprofits.

2024 filings • 501(c)6 • $1M-$5M nonprofits • Annualized from 2023 to 2024

Assets

Up

$1,156,608

Up $255,382 (+28%) from 2023

Net Assets

Up

$853,384

Up $227,880 (+36%) from 2023

Liabilities

Up

$303,224

Up $27,502 (+10.0%) from 2023

Revenue

Down

$719,723

Down $40,277 (-5.3%) from 2023

Expenses

Down

$491,843

Down $277,356 (-36%) from 2023

Net Income

Up

$227,880

Up $237,079 (+2577%) from 2023

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$1.5M$1.0M$500K$0Assets 2020: $726,531Liabilities 2020: $279,676Net Assets 2020: $446,8552020Assets 2021: $868,101Liabilities 2021: $101,657Net Assets 2021: $766,4442021Assets 2022: $685,644Liabilities 2022: $50,941Net Assets 2022: $634,7032022Assets 2023: $901,226Liabilities 2023: $275,722Net Assets 2023: $625,5042023Assets 2024: $1,156,608Liabilities 2024: $303,224Net Assets 2024: $853,3842024

Highlighted filing

2024

Assets$1,156,608
Liabilities$303,224
Net Assets$853,384

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.0M$500K$0-$500KRevenue 2020: $500,000Expenses 2020: $53,145Net Income 2020: $446,8552020Revenue 2021: $600,000Expenses 2021: $280,411Net Income 2021: $319,5892021Revenue 2022: $406,250Expenses 2022: $537,991Net Income 2022: -$131,7412022Revenue 2023: $760,000Expenses 2023: $769,199Net Income 2023: -$9,1992023Revenue 2024: $719,723Expenses 2024: $491,843Net Income 2024: $227,8802024

Highlighted filing

2024

Revenue$719,723
Expenses$491,843
Net Income$227,880
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
Mar 7, 2025
Return Version
2024v5.0
Gross Receipts
$721,667
Mission and Program Overview

Mission

Our mission is to collaboratively advance the most pressing issues and opportunities in subcutaneous dosage and delivery in a precompetitive manner.

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$564,090$646,055▲ $81,965
Intangible Assets$337,136$327,220▼ $9,916
Prepaid Expenses and Deferred Charges-$183,333-
Total Assets$901,226$1,156,608▲ $255,382
Liabilities
Other Liabilities-$300,000-
Accounts Payable and Accrued Expenses$275,722$3,224▼ $272,498
Total Liabilities$275,722$303,224▲ $27,502
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$625,504$853,384▲ $227,880
Total Net Assets Fund Balance$625,504$853,384▲ $227,880
Total Liabilities and Net Assets / Fund Balance$901,226$1,156,608▲ $255,382
Compensation and Service Providers

Board Members and Trustees

NameTitle
Donna FrenchPresident
Monica AdamsDirector
David KangTreasurer
Sachin MittalVice Preside

Highest Paid Contractors

ContractorServicesLocationCompensation
Charles River AssociatesManagement129 SUMMIT AVE 200, Summit, NJ 07901$521,822
Gerson Lehrman Group INCResearch60 EAST 42ND ST 3RD FL, New York, NY 10165$220,000
Revenue and Support

Revenue Composition

Contributions and Grants
$0
Program Service Revenue
$721,667
Investment Income
$-1,944
Other Revenue
$0
Change in Net Assets
$227,880
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$491,843
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Fees for Services Management---$311,970
Fees for Services Other---$119,589
Depreciation Depletion---$37,972
Fees for Services Legal---$18,175
Fees for Services Accounting---$1,809
Information Technology---$1,700
Office Expenses---$628
Total Functional Expenses$0$0$0$491,843
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
In-house lobbying only
Yes
Subject to proxy tax
Yes
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Member Deposits$300,000
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
Yes
Management duties delegated
Yes

Governance Explanations

Form 990, Page 6, Part VI, Line 3

The organization delegates the majority of operations secretariat duties to the management company, vital technical marketing, inc. Including but not limited to administration of the majority of meetings, assistance with membership duties and all financial duties.

Form 990, Page 6, Part VI, Line 6

Governing board members: industry experts in subcutaneous drug development & delivery who guide the overall direction of the sc consortium through voting rights and serving as sub-team leads and/or participants. Sub-team collaborators: individuals who are not on the governing board but who actively contribute to sub-team workstreams. These collaborators may belong to an organization contributing to the governing board or be another stakeholder in the sc ecosystem and are directly involved in driving forward sc consortium workstreams.

Form 990, Page 6, Part VI, Line 7A

Members elect members of the governing body.

Form 990, Page 6, Part VI, Line 7B

Yes, major decisions of the governing body are approved by the governing board members through a voting process, as written in the consortium's bylaws.

Form 990, Page 6, Part VI, Line 11B

No process was used by the organization to review form 990.

Form 990, Page 6, Part VI, Line 12C

The consortium regularly monitors and enforces compliance by requiring all organizational representatives (including board members and committee members) to: annually sign an affirmation of conflict of interest policy and disclosure form confirming their understanding and agreement to comply. Disclose any potential conflicts, which are reviewed by the board. Recuse themselves from discussions and votes where a conflict exists. Undergo periodic reviews to ensure compliance with tax-exempt requirements and ethical standards.

Form 990, Page 6, Part VI, Line 19

The organization makes its governing documents and financial statements available to the public upon written request.

Filing and Contact Details

Filer

Filer Name
Subcutaneous Drug Development
EIN
85-0837695
Phone
5036190505
Address
3855 SW 153RD DRIVE, BEAVERTON, OR 97003

Signing Officer

Name
Donna French
Title
President
Phone
5036190505
Signed
2025-03-07
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Donna French
Formed
2020
Legal Domicile
De
Voting Board Members
4
Independent Board Members
4
Employees
0
Volunteers
4

Preparer

Firm
Skcpa & Co
Address
10260 SW GREENBURG ROAD SUITE 1000, PORTLAND, OR 97223-5526
Preparer
Sean S Kim
Phone
5032931040
Supplemental Narrative

Additional Explanations

Form 990, Page 1, Part I, Line 6

Officers and board directors

Form 990, Part IX, Line 11G

Sustainability & pp/pe 96,589 0 0 hdhv 23,000 0 0 total 119,589 0 0

Raw XML Appendix285 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt0275722
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt03224
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0OUR MISSION IS TO COLLABORATIVELY ADVANCE THE MOST PRESSING ISSUES AND OPPORTUNITIES IN SUBCUTANEOUS DOSAGE AND DELIVERY IN A PRECOMPETITIVE MANNER.
IRS990/AnnualDisclosureCoveredPrsnInd0true
IRS990/BackupWthldComplianceInd0true
IRS990/BooksInCareOfDetail/PersonNm0VITAL TECHNICAL MARKETING INC
IRS990/BooksInCareOfDetail/PhoneNum05036190505
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt03855 SW 153RD DRIVE
IRS990/BooksInCareOfDetail/USAddress/CityNm0BEAVERTON
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0OR
IRS990/BooksInCareOfDetail/USAddress/ZIPCd097003
IRS990/BusinessRlnWith35CtrlEntInd0false
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/BOYAmt0564090
IRS990/CashNonInterestBearingGrp/EOYAmt0646055
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CntrctRcvdGreaterThan100KCnt02
IRS990/CollectionsOfArtInd0false
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0false
IRS990/CompensationProcessOtherInd0false
IRS990/ConflictOfInterestPolicyInd0true
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/ContractorCompensationGrp/CompensationAmt0521822
IRS990/ContractorCompensationGrp/CompensationAmt1220000
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt0129 SUMMIT AVE 200
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt160 EAST 42ND ST 3RD FL
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0SUMMIT
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm1NEW YORK
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0NJ
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd1NY
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd007901
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd110165
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0CHARLES RIVER ASSOCIATES
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt1GERSON LEHRMAN GROUP INC
IRS990/ContractorCompensationGrp/ServicesDesc0MANAGEMENT
IRS990/ContractorCompensationGrp/ServicesDesc1RESEARCH
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt00
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt0-1944
IRS990/CYOtherExpensesAmt0491843
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt0721667
IRS990/CYRevenuesLessExpensesAmt0227880
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt0491843
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0719723
IRS990/DecisionsSubjectToApprovaInd0true
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0true
IRS990/DepreciationDepletionGrp/TotalAmt037972
IRS990/Desc0PATIENT PREFERENCE & EXPERIENCE: PUBLISHED "PHARMACEUTICAL AND BIOTECH INDUSTRY PERSPECTIVES ON OPTIMIZING PATIENT EXPERIENCE AND TREATMENT ADHERENCE THROUGH SUBCUTANEOUS DRUG DELIVERY DESIGN" IN Q2, FINALIZED A PROPOSAL FOR ADDITIONAL RESEARCH WITH THE SUSTAINABILITY WORKSTREAM, AND COMPLETED A COMPETITIVE BID WITH THREE POTENTIAL VENDORS.
IRS990/DescribedInSection501c3Ind0false
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0false
IRS990/DonorAdvisedFundInd0false
IRS990/DonorRstrOrQuasiEndowmentsInd0false
IRS990/ElectionOfBoardMembersInd0true
IRS990/EmployeeCnt00
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FederalGrantAuditRequiredInd0false
IRS990/FeesForServicesAccountingGrp/TotalAmt01809
IRS990/FeesForServicesLegalGrp/TotalAmt018175
IRS990/FeesForServicesManagementGrp/TotalAmt0311970
IRS990/FeesForServicesOtherGrp/TotalAmt0119589
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt05.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt15.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt25.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt35.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/PersonNm0DONNA FRENCH
IRS990/Form990PartVIISectionAGrp/PersonNm1SACHIN MITTAL
IRS990/Form990PartVIISectionAGrp/PersonNm2DAVID KANG
IRS990/Form990PartVIISectionAGrp/PersonNm3MONICA ADAMS
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1VICE PRESIDE
IRS990/Form990PartVIISectionAGrp/TitleTxt2TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd0false
IRS990/FormationYr02020
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GainOrLossGrp/OtherAmt0-1944
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt04
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt0721667
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt04
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIXInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/TotalAmt01700
IRS990/IntangibleAssetsGrp/BOYAmt0337136
IRS990/IntangibleAssetsGrp/EOYAmt0327220
IRS990/InvestmentInJointVentureInd0false
IRS990/IRPDocumentCnt02
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0DE
IRS990/LessCostOthBasisSalesExpnssGrp/OtherAmt01944
IRS990/LoanOutstandingInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0true
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0OUR MISSION IS TO COLLABORATIVELY ADVANCE THE MOST PRESSING ISSUES AND OPPORTUNITIES IN SUBCUTANEOUS DOSAGE AND DELIVERY IN A PRECOMPETITIVE MANNER.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt0625504
IRS990/NetAssetsOrFundBalancesEOYAmt0853384
IRS990/NetGainOrLossInvestmentsGrp/RelatedOrExemptFuncIncomeAmt0-1944
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0-1944
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt0625504
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt0853384
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd0false
IRS990/OfficeExpensesGrp/TotalAmt0628
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501cInd0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherLiabilitiesGrp/EOYAmt0300000
IRS990/PartialLiquidationInd0false
IRS990/PoliticalCampaignActyInd0false
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt0183333
IRS990/PrincipalOfficerNm0DONNA FRENCH
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgramServiceRevenueGrp/BusinessCd0541700
IRS990/ProgramServiceRevenueGrp/Desc0MEMBERSHIP DUES
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt0721667
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt0721667
IRS990/ProgSrvcAccomActy2Grp/Desc0HIGH DOSE HIGH VOLUME: PUBLISHED "TOWARDS MORE TOLERABLE SUBCUTANEOUS ADMINISTRATION: REVIEW OF CONTRIBUTING FACTORS FOR IMPROVING COMBINATION PRODUCT DESIGN," DRAFTED AN INDUSTRY-WIDE SURVEY AND ESTABLISHED A FRAMEWORK FOR A PUBLICATION ON THE HDHV INTEGRATED ROADMAP, AND FINALIZED A SURVEY AND FRAMEWORK FOR A PUBLICATION ON THE HARMONIZATION OF PAIN SCORING IN SC CLINICAL TRIALS.
IRS990/ProgSrvcAccomActy3Grp/Desc0CLINICAL DEVELOPMENT & REGULATORY STRATEGY: PRESENTED AT THE CRS ANNUAL MEETING ON DEBUNKING MYTHS OF SC DELIVERY, EXECUTED A SURVEY REGARDING CLINICAL DEVELOPMENT AND REGULATORY STRATEGIES FOR HIGH-DOSE BIOLOGICS, AND COMPLETED WRITING OF A MANUSCRIPT BASED ON THE SURVEY RESULTS, WITH SUBMISSION EXPECTED BY THE END OF THE YEAR.
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYOtherExpensesAmt0769199
IRS990/PYProgramServiceRevenueAmt0760000
IRS990/PYRevenuesLessExpensesAmt0-9199
IRS990/PYTotalExpensesAmt0769199
IRS990/PYTotalRevenueAmt0760000
IRS990/ReconcilationRevenueExpnssAmt0227880
IRS990/RegularMonitoringEnfrcInd0true
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0false
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0true
IRS990/ReportProgramRelatedInvstInd0false
IRS990/ScheduleBRequiredInd0false
IRS990ScheduleC/AgreeCarryoverPriorYearInd0false
IRS990ScheduleC/OnlyInHouseLobbyingInd0true
IRS990ScheduleC/SubstantiallyAllDuesNondedInd0false
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Amt0300000
IRS990ScheduleD/OtherLiabilitiesOrgGrp/Desc0MEMBER DEPOSITS
IRS990ScheduleD/TotalLiabilityAmt0300000
IRS990/ScheduleJRequiredInd0false
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0OFFICERS AND BOARD DIRECTORS
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1THE ORGANIZATION DELEGATES THE MAJORITY OF OPERATIONS SECRETARIAT DUTIES TO THE MANAGEMENT COMPANY, VITAL TECHNICAL MARKETING, INC. INCLUDING BUT NOT LIMITED TO ADMINISTRATION OF THE MAJORITY OF MEETINGS, ASSISTANCE WITH MEMBERSHIP DUTIES AND ALL FINANCIAL DUTIES.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2GOVERNING BOARD MEMBERS: INDUSTRY EXPERTS IN SUBCUTANEOUS DRUG DEVELOPMENT & DELIVERY WHO GUIDE THE OVERALL DIRECTION OF THE SC CONSORTIUM THROUGH VOTING RIGHTS AND SERVING AS SUB-TEAM LEADS AND/OR PARTICIPANTS. SUB-TEAM COLLABORATORS: INDIVIDUALS WHO ARE NOT ON THE GOVERNING BOARD BUT WHO ACTIVELY CONTRIBUTE TO SUB-TEAM WORKSTREAMS. THESE COLLABORATORS MAY BELONG TO AN ORGANIZATION CONTRIBUTING TO THE GOVERNING BOARD OR BE ANOTHER STAKEHOLDER IN THE SC ECOSYSTEM AND ARE DIRECTLY INVOLVED IN DRIVING FORWARD SC CONSORTIUM WORKSTREAMS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3MEMBERS ELECT MEMBERS OF THE GOVERNING BODY.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4YES, MAJOR DECISIONS OF THE GOVERNING BODY ARE APPROVED BY THE GOVERNING BOARD MEMBERS THROUGH A VOTING PROCESS, AS WRITTEN IN THE CONSORTIUM'S BYLAWS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5NO PROCESS WAS USED BY THE ORGANIZATION TO REVIEW FORM 990.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6THE CONSORTIUM REGULARLY MONITORS AND ENFORCES COMPLIANCE BY REQUIRING ALL ORGANIZATIONAL REPRESENTATIVES (INCLUDING BOARD MEMBERS AND COMMITTEE MEMBERS) TO: ANNUALLY SIGN AN AFFIRMATION OF CONFLICT OF INTEREST POLICY AND DISCLOSURE FORM CONFIRMING THEIR UNDERSTANDING AND AGREEMENT TO COMPLY. DISCLOSE ANY POTENTIAL CONFLICTS, WHICH ARE REVIEWED BY THE BOARD. RECUSE THEMSELVES FROM DISCUSSIONS AND VOTES WHERE A CONFLICT EXISTS. UNDERGO PERIODIC REVIEWS TO ENSURE COMPLIANCE WITH TAX-EXEMPT REQUIREMENTS AND ETHICAL STANDARDS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt7THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON WRITTEN REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt8SUSTAINABILITY & PP/PE 96,589 0 0 HDHV 23,000 0 0 TOTAL 119,589 0 0
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PAGE 1, PART I, LINE 6
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PAGE 6, PART VI, LINE 3
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 6, PART VI, LINE 6
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PAGE 6, PART VI, LINE 7A
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PAGE 6, PART VI, LINE 7B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6FORM 990, PAGE 6, PART VI, LINE 12C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc7FORM 990, PAGE 6, PART VI, LINE 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc8FORM 990, PART IX, LINE 11G
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/SubjectToExcsTaxNetInvstIncInd0false
IRS990/SubjectToProxyTaxInd0true
IRS990/SubjToTaxRmnrtnExPrchtPymtInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt0901226
IRS990/TotalAssetsEOYAmt01156608
IRS990/TotalAssetsGrp/BOYAmt0901226
IRS990/TotalAssetsGrp/EOYAmt01156608
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt00
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt00
IRS990/TotalFunctionalExpensesGrp/TotalAmt0491843
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt0275722
IRS990/TotalLiabilitiesEOYAmt0303224
IRS990/TotalLiabilitiesGrp/BOYAmt0275722
IRS990/TotalLiabilitiesGrp/EOYAmt0303224
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt0625504
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt0853384
IRS990/TotalProgramServiceRevenueAmt0721667
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt0719723
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0719723
IRS990/TotalVolunteersCnt04
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt0901226
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt01156608
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt03855 SW 153RD DRIVE
IRS990/USAddress/CityNm0BEAVERTON
IRS990/USAddress/StateAbbreviationCd0OR
IRS990/USAddress/ZIPCd097003
IRS990/VotingMembersGoverningBodyCnt04
IRS990/VotingMembersIndependentCnt04
IRS990/WebsiteAddressTxt0SUBCUTANEOUSCONSORTIUM.ORG
IRS990/WhistleblowerPolicyInd0false
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0DONNA FRENCH
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum05036190505
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-03-07
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0SUBCUTANEOUS DRUG DEVELOPMENT
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0& DELIVERY CONSORTIUM INC
ReturnHeader/Filer/BusinessNameControlTxt0SUBC
ReturnHeader/Filer/EIN0850837695
ReturnHeader/Filer/PhoneNum05036190505
ReturnHeader/Filer/USAddress/AddressLine1Txt03855 SW 153RD DRIVE
ReturnHeader/Filer/USAddress/CityNm0BEAVERTON
ReturnHeader/Filer/USAddress/StateAbbreviationCd0OR
ReturnHeader/Filer/USAddress/ZIPCd097003
ReturnHeader/IRSResponsiblePrtyInfoCurrInd0true
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0731691547
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0SKCPA & CO
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt010260 SW GREENBURG ROAD SUITE 1000
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0PORTLAND
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0OR
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0972235526
ReturnHeader/PreparerPersonGrp/PhoneNum05032931040
ReturnHeader/PreparerPersonGrp/PreparationDt02025-03-07
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0SEAN S KIM
ReturnHeader/ReturnTs02025-04-14T22:43:28-04:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02024-01-01
ReturnHeader/TaxPeriodEndDt02024-12-31
ReturnHeader/TaxYr02024

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings